000154421 001__ 154421
000154421 005__ 20240229123101.0
000154421 0247_ $$2doi$$a10.1016/j.jmoldx.2020.03.005
000154421 0247_ $$2pmid$$apmid:32247864
000154421 0247_ $$2ISSN$$a1525-1578
000154421 0247_ $$2ISSN$$a1943-7811
000154421 0247_ $$2altmetric$$aaltmetric:79215059
000154421 037__ $$aDKFZ-2020-00752
000154421 041__ $$aeng
000154421 082__ $$a610
000154421 1001_ $$0P:(DE-HGF)0$$aSchmidt, Stefan$$b0
000154421 245__ $$aComparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma.
000154421 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2020
000154421 3367_ $$2DRIVER$$aarticle
000154421 3367_ $$2DataCite$$aOutput Types/Journal article
000154421 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1595594607_30774
000154421 3367_ $$2BibTeX$$aARTICLE
000154421 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154421 3367_ $$00$$2EndNote$$aJournal Article
000154421 500__ $$a2020 Jun;22(6):801-810
000154421 520__ $$aIn this manuscript we compare the expression and applicability of biomarkers, from single genes and gene signatures, identified in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) using the GeneChip Human Transcriptome Array 2.0, nCounter and real-time polymerase chain reaction (RT-PCR) analyses. Two multicentre retrospective HNSCC patient cohorts of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG), who received postoperative radiochemotherapy (PORT-C) or primary radiochemotherapy (primary RCTx) were considered. RT-PCR was performed for a limited number of 38 genes of the PORT-C cohort only. Correlations between the methods were evaluated by the Spearman rank correlation coefficient ρ. Patients were stratified based on the expression of putative cancer stem cell markers, hypoxia-associated gene signatures and a previously developed 7-gene signature. Loco-regional tumour control (LRC) was compared between these patient subgroups using log-rank tests. Gene expressions obtained from nCounter analyses were moderately correlated to GeneChip analyses (median ρ≈0.68). A higher correlation was obtained between nCounter analyses and RT-PCR (median ρ=0.84). Significant associations to LRC were observed for most of the considered biomarkers evaluated by both GeneChip and nCounter analyses. In general, all applied biomarkers (single genes and gene signatures) classified about 70% to 85% of the patients similarly. Overall, gene signatures seem to be more robust and showed a better transferability between different measurement methods.
000154421 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000154421 588__ $$aDataset connected to CrossRef, PubMed,
000154421 7001_ $$0P:(DE-He78)81b719227985a27b1b77ed6766094319$$aLinge, Annett$$b1$$udkfz
000154421 7001_ $$0P:(DE-HGF)0$$aGroßer, Marianne$$b2
000154421 7001_ $$0P:(DE-HGF)0$$aLohaus, Fabian$$b3
000154421 7001_ $$aGudziol, Volker$$b4
000154421 7001_ $$aNowak, Alexander$$b5
000154421 7001_ $$0P:(DE-HGF)0$$aTinhofer, Ingeborg$$b6
000154421 7001_ $$0P:(DE-HGF)0$$aBudach, Volker$$b7
000154421 7001_ $$0P:(DE-HGF)0$$aSak, Ali$$b8
000154421 7001_ $$0P:(DE-HGF)0$$aStuschke, Martin$$b9
000154421 7001_ $$0P:(DE-HGF)0$$aBalermpas, Panagiotis$$b10
000154421 7001_ $$0P:(DE-HGF)0$$aRödel, Claus$$b11
000154421 7001_ $$0P:(DE-HGF)0$$aSchäfer, Henning$$b12
000154421 7001_ $$0P:(DE-HGF)0$$aGrosu, Anca-Ligia$$b13
000154421 7001_ $$0P:(DE-He78)360c5bc2b71a849e35aca747c041dda7$$aAbdollahi, Amir$$b14$$udkfz
000154421 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b15$$udkfz
000154421 7001_ $$0P:(DE-HGF)0$$aGanswindt, Ute$$b16
000154421 7001_ $$0P:(DE-HGF)0$$aBelka, Claus$$b17
000154421 7001_ $$0P:(DE-HGF)0$$aPigorsch, Steffi$$b18
000154421 7001_ $$0P:(DE-HGF)0$$aCombs, Stephanie E$$b19
000154421 7001_ $$0P:(DE-He78)a71604d1adbf3bced939fcfcf2c7ff32$$aMönnich, David$$b20
000154421 7001_ $$0P:(DE-HGF)0$$aZips, Daniel$$b21
000154421 7001_ $$0P:(DE-HGF)0$$aBaretton, Gustavo B$$b22
000154421 7001_ $$0P:(DE-HGF)0$$aBuchholz, Frank$$b23
000154421 7001_ $$0P:(DE-He78)933f7d725ac87378f459623783585a1f$$aBaumann, Michael$$b24$$udkfz
000154421 7001_ $$0P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9$$aKrause, Mechthild$$b25$$udkfz
000154421 7001_ $$0P:(DE-HGF)0$$aLöck, Steffen$$b26
000154421 7001_ $$aDKTK-ROG$$b27$$eCollaboration Author
000154421 773__ $$0PERI:(DE-600)2032654-3$$a10.1016/j.jmoldx.2020.03.005$$gp. S1525157820300763$$n6$$p801-810$$tThe journal of molecular diagnostics$$v22$$x1525-1578$$y2020
000154421 909CO $$ooai:inrepo02.dkfz.de:154421$$pVDB
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)81b719227985a27b1b77ed6766094319$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)360c5bc2b71a849e35aca747c041dda7$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a71604d1adbf3bced939fcfcf2c7ff32$$aDeutsches Krebsforschungszentrum$$b20$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b21$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b23$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)933f7d725ac87378f459623783585a1f$$aDeutsches Krebsforschungszentrum$$b24$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9$$aDeutsches Krebsforschungszentrum$$b25$$kDKFZ
000154421 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000154421 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000154421 9141_ $$y2020
000154421 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154421 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154421 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000154421 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ MOL DIAGN : 2017
000154421 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154421 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154421 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000154421 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154421 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154421 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000154421 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000154421 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154421 9201_ $$0I:(DE-He78)DD01-20160331$$kDD01$$lDKTK DD zentral$$x0
000154421 9201_ $$0I:(DE-He78)BE01-20160331$$kBE01$$lDKTK BE zentral$$x1
000154421 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK ED ES zentral$$x2
000154421 9201_ $$0I:(DE-He78)FM01-20160331$$kFM01$$lDKTK FM zentral$$x3
000154421 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x4
000154421 9201_ $$0I:(DE-He78)FR01-20160331$$kFR01$$lDKTK FR zentral$$x5
000154421 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK MU LMU zentral$$x6
000154421 9201_ $$0I:(DE-He78)E210-20160331$$kE210$$lE210 Translationale Radioonkologie$$x7
000154421 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lE050 KKE Strahlentherapie$$x8
000154421 9201_ $$0I:(DE-He78)TU01-20160331$$kTU01$$lDKTK TU zentral$$x9
000154421 980__ $$ajournal
000154421 980__ $$aVDB
000154421 980__ $$aI:(DE-He78)DD01-20160331
000154421 980__ $$aI:(DE-He78)BE01-20160331
000154421 980__ $$aI:(DE-He78)ED01-20160331
000154421 980__ $$aI:(DE-He78)FM01-20160331
000154421 980__ $$aI:(DE-He78)HD01-20160331
000154421 980__ $$aI:(DE-He78)FR01-20160331
000154421 980__ $$aI:(DE-He78)MU01-20160331
000154421 980__ $$aI:(DE-He78)E210-20160331
000154421 980__ $$aI:(DE-He78)E050-20160331
000154421 980__ $$aI:(DE-He78)TU01-20160331
000154421 980__ $$aUNRESTRICTED